Navigation Links
DermTech Adds Allan C. Halpern, MD, Chief of Dermatology at Memorial Sloan- Kettering Cancer Center, to Company's Melanoma Advisory Board
Date:3/5/2008

LA JOLLA, Calif., March 5 /PRNewswire/ -- DermTech, a biotechnology company developing molecular diagnostics for the early detection of melanoma and other diseases, today announced that Allan C. Halpern, MD, has joined DermTech's Melanoma Advisory Board. Dr. Halpern is Chief of Dermatology at Memorial Sloan-Kettering Cancer Center and widely recognized as an expert in the early detection and management of melanoma in high-risk individuals.

"We are delighted and honored to welcome Dr. Halpern to our Melanoma Advisory Board," said George Schwartz, CEO, DermTech. "Dr. Halpern is a world leader in the area of melanoma and strategies for improved diagnosis and prevention of this disease that, if identified early, has an extremely high cure rate. DermTech will clearly benefit from his significant experience as we move toward clinical trials of our novel, non-invasive molecular diagnostic product for melanoma early detection."

"I am looking forward to working with the company and the outstanding panel of dermatologists and melanoma experts already on this advisory board," said Allan Halpern, MD. Other Melanoma Advisory Board members include: Boris Bastian, MD, David Polsky, MD, PhD, and Harold S. Rabinovitz, MD.

Allan Halpern, MD, is a board-certified internist and dermatologist. In addition to his role as Chief of Dermatology at MSKCC, he is co-leader of the Center's Melanoma Disease Management Team, which incorporates the expertise of doctors in surgery, medical oncology, clinical immunology, dermatology, pathology, and radiation oncology to diagnose and treat melanoma. He pioneered the use of digital whole-body photography to assist in the detection of changing moles in patients with dysplastic nevi (large, irregular colored or shaped moles). Currently, his research is focused on epidemiologic (population-based) studies with a subset of this research devoted to the study of the genetic and environmental factors that influence the development of moles in children and adolescents. Dr. Halpern received his medical degree from the Albert Einstein College of Medicine in New York and completed his Dermatology residency at the Hospital of the University of Pennsylvania. He has presented and published extensively on melanoma detection.

About DermTech:

Headquartered in La Jolla, California, DermTech International is focused on the development and validation of molecular tests using specimens obtained from the skin. The company's proprietary Epidermal Genetic Information Retrieval (EGIR(TM)) technology is in clinical studies to evaluate its potential as a non-invasive diagnostic for melanoma and other major diseases. It is also being studied in the context of tracking treatment efficacy for a variety of dermatologic and other conditions, including the effects of drugs on skin at the molecular level in advance of observable clinical results. DermTech is actively pursuing research using EGIR(TM) and its applications in the areas of melanoma, prostate cancer and various skin disorders, such as psoriasis. For additional information visit http://www.dermtech.com.

Contacts:

DermTech

George Schwartz

CEO

858.450.4222

For DermTech

Jennifer Larson

415.409.2729

jlarson@labfive.com


'/>"/>
SOURCE DermTech
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Radlink Names Allan Christensen Vice President of Technical Services
2. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
3. WorldHeart Appoints David Pellone Chief Financial Officer
4. Mediware Names Thomas K. Mann Chief Executive Officer
5. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
6. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
7. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
8. Coalition America Announces Addition of Mollie Gordon Brown as Chief Strategy Officer
9. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
10. Karen Vigil Named Senior Vice President and Chief Executive Officer, Blue Shield of Californias Individual, Small Group, and Government Business Unit
11. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Texas (PRWEB) , ... March 27, 2017 , ... ... at the GTEC Orange facility from 8:00am-10:00am on Monday, April 3rd to commemorate ... and will be an opportunity for area-residents to celebrate two great years while ...
(Date:3/26/2017)... ... March 26, 2017 , ... Local physician Dr. Justin ... a prestigious award honoring the top influencers on RealSelf—the most trusted online destination ... doctors and clinics. , In 2016, more than 82 million people visited RealSelf ...
(Date:3/24/2017)... ... March 24, 2017 , ... Vighter established its NAEMT Authorized ... providing Prehospital Trauma Life Support (PHTLS) course scholarships to four medics assigned to ... developed in cooperation with the American College of Surgeons to promote critical thinking ...
(Date:3/24/2017)... ... 24, 2017 , ... The Radiology Business Management Association (RBMA) has ... now in their 12th year, are among the most prestigious in radiology marketing because ... awards were retooled to recognize achievements in both large budget (over $5,000) and small ...
(Date:3/24/2017)... ... March 24, 2017 , ... Mlynarek Insurance ... to families and business owners across eastern Michigan, is connecting with the Oxford/Orion ... with financial difficulties. , The Oxford/Orion FISH Food Pantry works to ensure homeless, ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Columbia, March 27, 2017  Sophiris Bio Inc. ... "Sophiris"), a clinical late-stage biopharmaceutical company developing topsalysin ... diseases, today reported fourth quarter and full year ... Key Corporate Highlights: ... Prostate Cancer. During 2016, the Company reported successful ...
(Date:3/27/2017)... 27, 2017   Pulmatrix, Inc . (NASDAQ: PULM), a ... serious pulmonary diseases, today announced that it has added two ... and asthma to its Scientific Advisory Board . ... Richard B. Moss , MD, former chief of the Pediatric ... Fibrosis Center at Stanford University, and ...
(Date:3/27/2017)... , March 27, 2017  iCAD (Nasdaq: ICAD), ... solutions and radiation therapy for the early identification ... Tomo Detection received Premarket Approval (PMA) from the ... Detection is a first-of-its-kind, concurrent-read computer aided detection ... the latest innovation available on the PowerLook® Breast ...
Breaking Medicine Technology: